Suppr超能文献

人肾硫嘌呤甲基转移酶。用S-腺苷-L-甲硫氨酸进行光亲和标记。

Human kidney thiopurine methyltransferase. Photoaffinity labeling with S-adenosyl-L-methionine.

作者信息

Van Loon J A, Szumlanski C L, Weinshilboum R M

机构信息

Department of Pharmacology, Mayo Clinic/Mayo Foundation, Rochester, MN 55905.

出版信息

Biochem Pharmacol. 1992 Aug 18;44(4):775-85. doi: 10.1016/0006-2952(92)90416-g.

Abstract

Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of heterocyclic and aromatic sulfhydryl compounds such as the thiopurine drug 6-mercaptopurine (6-MP). TPMT activity in human tissue is regulated by a common genetic polymorphism, and "pharmacogenetic" variation in TPMT activity is an important factor in individual differences in thiopurine drug metabolism, toxicity and therapeutic efficacy. Human renal tissue contains two isozymes of TPMT, Peak I and Peak II, that can be separated by ion exchange chromatography. Our experiments were performed to determine whether S-adenosyl-L-methionine (Ado-Met), the methyl donor for the TPMT reaction, could be used as a photoaffinity ligand for these isozymes as one step in the study of the molecular basis for the TPMT genetic polymorphism. When [3H-methyl]Ado-Met and partially purified preparations of either isozyme of human kidney TPMT were exposed to ultraviolet light at 254 nm, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a 35 kDa protein was the predominant species that was radioactively labeled. The same 35 kDa protein was photoaffinity labeled with [14C-carboxyl]Ado-Met, demonstrating that labeling involved covalent binding of Ado-Met rather than methylation of the protein. TPMT enzymatic activity co-eluted with the 35 kDa protein during sequential DEAE ion exchange, gel filtration and hydroxylapatite chromatography. Inhibitors of TPMT enzymatic activity including S-adenosyl-L-homocysteine, sinefungin, 6-methylmercaptopurine and 3,4-dimethoxy-5-hydroxybenzoic acid inhibited photoaffinity labeling of the 35 kDa protein in preparations of both TPMT Peak I and Peak II isozymes in a concentration-dependent fashion, as did 6-MP, the methyl acceptor substrate for the TPMT reaction. All of these results were compatible with the conclusion that the 35 kDa protein was TPMT. Photoaffinity labeling of TPMT with [3H]Ado-Met should make it possible to purify the enzyme to homogeneity and to study amino acid sequences at or near its active site.

摘要

硫嘌呤甲基转移酶(TPMT)催化杂环和芳香族巯基化合物的S-甲基化反应,如硫嘌呤药物6-巯基嘌呤(6-MP)。人体组织中的TPMT活性受一种常见基因多态性的调控,TPMT活性的“药物遗传学”变异是硫嘌呤药物代谢、毒性和治疗效果个体差异的一个重要因素。人肾组织含有两种TPMT同工酶,峰I和峰II,可通过离子交换色谱法分离。我们进行实验以确定TPMT反应的甲基供体S-腺苷-L-甲硫氨酸(Ado-Met)是否可作为这些同工酶的光亲和配体,这是研究TPMT基因多态性分子基础的一个步骤。当将[3H-甲基]Ado-Met与人肾TPMT任一同工酶的部分纯化制剂在254nm波长下暴露于紫外光,随后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳时,一个35kDa的蛋白质是被放射性标记的主要条带。相同的35kDa蛋白质也被[14C-羧基]Ado-Met光亲和标记,表明标记涉及Ado-Met的共价结合而非蛋白质的甲基化。在连续的DEAE离子交换、凝胶过滤和羟基磷灰石色谱过程中,TPMT酶活性与35kDa蛋白质共洗脱。TPMT酶活性抑制剂,包括S-腺苷-L-高半胱氨酸、杀稻瘟菌素、6-甲基巯基嘌呤和3,4-二甲氧基-5-羟基苯甲酸,以浓度依赖的方式抑制TPMT峰I和峰II同工酶制剂中35kDa蛋白质的光亲和标记,TPMT反应的甲基受体底物6-MP也是如此。所有这些结果都与35kDa蛋白质是TPMT这一结论相符。用[3H]Ado-Met对TPMT进行光亲和标记应该能够将该酶纯化至同质,并研究其活性位点或附近的氨基酸序列。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验